🎉 First CBT session for social anxiety 10% off — use code WELCOME10 · from ₹999📅 Book Now →✕
28 CBT-Focused
therapists online now · Book by chat if calling feels hard
Online Social Anxiety counselling that actually works.
Evidence-based online CBT and psychiatry for social anxiety disorder — the fear of judgement, blushing, blank mind, avoidance, meetings you dread, calls you postpone, dating you avoid. Delivered worldwide via video, audio, or chat-only if speaking still feels too much. 550+ licensed clinical psychologists trained in Clark & Wells CBT-SAD, Heimberg group CBT, exposure therapy and ACT. NICE CG159 and APA-aligned. Whether it's public speaking, small talk, meetings, video calls, dating, eating in front of others, using public toilets, or something you haven't named yet — real change is possible.
Click Your Concern — See Which Counsellor Can Help.
Instantly matched to a certified counselling psychologist trained for exactly what
you are navigating — and a couple therapist if relationships are part of it.
28 CBT-SAD Focused
specialists online now, one careful match for you.
Every therapist and psychiatrist on HopeQure is background-verified before onboarding. Our SAD-focused psychologists are specifically trained in Clark & Wells CBT-SAD, Heimberg group CBT, Metacognitive Therapy, or ACT for SAD. Our SAD psychiatrists have specific experience with SSRI titration for social anxiety (paroxetine, sertraline, escitalopram, venlafaxine XR) and situational beta-blocker prescribing for performance SAD. Booking by chat only is completely fine — many of our clients start that way.
Single sessions or structured programmes. Pay per session, or commit to a package for continuity. Use code WELCOME10 for 10% off your first session ·
👥 Heimberg Group CBT-SAD: ₹6,999 for 12 weekly 2.5-hour group sessions with 4-6 peers · Cost-effective and often preferred by those who feel "alone" in SAD · Group format itself is powerful exposure practice · Ask about the next cohort →
Understanding Social Anxiety
&
Your Treatment Options
Social anxiety can affect how you feel, think and behave in everyday
social situations. Learn more about its different presentations,
CBT techniques, symptoms and evidence-based treatment approaches
in our complete guide.
Before you read on: This page describes mental health struggles and their treatment. Reaching out is a strength, not a weakness. If you're in a crisis or feel you might harm yourself, please contact your local emergency service right now, or reach our care coordinator on WhatsApp — we'll get you seen the same day.
Free Social Anxiety Check-in · 4 Gold-Standard SAD Screeners
Take stock of your social anxiety · in under 10 minutes.
Below are four widely-used, validated social anxiety self-report instruments — the same ones used in NHS IAPT services, Karolinska Institutet iCBT-SAD trials, US VA anxiety clinics, and every major CBT-SAD research study worldwide. Each measures something slightly different: Mini-SPIN (3-item ultra-brief screen), SPIN (17-item severity), LSAS (24-item gold standard — fear AND avoidance across specific situations), and SIAS-6 (interaction-specific anxiety). Results are interpreted for you instantly and privately. None diagnose SAD on its own — that requires a clinician — but they tell you whether your social anxiety is above the clinical threshold, and give your therapist a great starting point.
Instrument: Mini-SPIN · 3-item Social Phobia Inventory brief screenAge range: 13+ yearsConnor KM, Kobak KA, Churchill LE, Katzelnick D, Davidson JR. Depress Anxiety 2001;14(2):137-140 · Cutoff ≥6/12 has 89% sensitivity, 90% specificity for generalised SAD.
Mini-SPIN · 30-second social anxiety screen
The fastest validated social anxiety screener in clinical use — three items, 30 seconds, and remarkably accurate. Used as the first-line SAD screen in NHS IAPT services and primary care globally. In the past week, how much did each of these statements apply to you?
Scale: Not at all (0) · A little bit (1) · Somewhat (2) · Very much (3) · Extremely (4). Any total ≥6 out of 12 is a positive screen for SAD.
1. Fear of embarrassment causes me to avoid doing things or speaking to people.
2. I avoid activities in which I am the centre of attention.
3. Being embarrassed or looking stupid are among my worst fears.
Instrument: SPIN · Social Phobia Inventory (17 items)Age range: 13+ yearsConnor KM, Davidson JR, Churchill LE, Sherwood A, Foa E, Weisler RH. Br J Psychiatry 2000;176:379-386 · Free to use · Cutoff ≥19 has 79% sensitivity, 79% specificity for SAD diagnosis.
SPIN · Social Phobia Inventory · 17-item severity
The 17-item SPIN measures the three core symptom clusters of SAD — fear, avoidance, and physiological symptoms — over the past week. It's the most-used SAD severity measure in outcome research and clinical monitoring. Total ranges 0-68. Cutoffs: 0-20 minimal / sub-clinical · 21-30 mild · 31-40 moderate · 41-50 severe · 51-68 very severe SAD. Please tell us how much each of the following problems has bothered you during the past week.
Scale: Not at all (0) · A little bit (1) · Somewhat (2) · Very much (3) · Extremely (4).
1. I am afraid of people in authority.
2. I am bothered by blushing in front of people.
3. Parties and social events scare me.
4. I avoid talking to people I don't know.
5. Being criticised scares me a lot.
6. I avoid doing things or speaking to people for fear of embarrassment.
7. Sweating in front of people causes me distress.
8. I avoid going to parties.
9. I avoid activities in which I am the centre of attention.
10. Talking to strangers scares me.
11. I avoid having to give speeches.
12. I would do anything to avoid being criticised.
13. Heart palpitations bother me when I'm around people.
14. I am afraid of doing things when people might be watching.
15. Being embarrassed or looking stupid are among my worst fears.
16. I avoid speaking to anyone in authority.
17. Trembling or shaking in front of others is distressing to me.
Instrument: LSAS · Liebowitz Social Anxiety Scale · Fear Subscale (12 items)Age range: 18+ yearsLiebowitz MR. Social phobia. Mod Probl Pharmacopsychiatry 1987;22:141-173 · The gold-standard clinician / self-report measure for SAD severity and outcome monitoring. Full LSAS has 24 situations rated for both fear and avoidance (0-3 each); we present the 12 most-discriminating items rated for fear intensity.
LSAS · Fear intensity across social situations
The Liebowitz Social Anxiety Scale is the most-used clinical outcome measure for SAD, embedded in nearly every major CBT-SAD trial (Clark & Wells RCTs, Heimberg group CBT studies, Mayo-Wilson network meta-analysis). Rate the fear or anxiety you would feel in each situation over the past week. Total fear range 0-36 for this 12-item version. Rough cutoffs: 0-6 minimal · 7-14 mild · 15-22 moderate · 23-29 severe · 30+ very severe.
Scale: None (0) · Mild (1) · Moderate (2) · Severe (3). Rate based on how you would feel in each situation NOW, even if you avoid it.
1. Telephoning in public.
2. Participating in small groups.
3. Eating in public places.
4. Acting, performing, or giving a talk in front of an audience.
5. Going to a party.
6. Working while being observed.
7. Writing while being observed.
8. Calling someone you don't know very well.
9. Talking with people you don't know very well.
10. Meeting strangers.
11. Urinating in a public bathroom.
12. Expressing disagreement or disapproval to people you don't know very well.
Instrument: SIAS-6 · Social Interaction Anxiety Scale (short form)Age range: 16+ yearsPeters L, Sunderland M, Andrews G, Rapee RM, Mattick RP. Psychol Assess 2012;24(1):66-76 · Six-item short form derived from Mattick & Clarke (1998) SIAS · Cutoff ≥7 has strong sensitivity for SAD.
SIAS-6 · Social interaction anxiety
SIAS-6 specifically measures anxiety in reciprocal social interaction (talking with people) rather than performance situations — an important distinguisher from SPS/LSAS which capture both. Complements the SPIN and LSAS. Total range 0-24. Cutoff: ≥7 suggests clinically significant social interaction anxiety.
Scale: Not at all characteristic (0) · Slightly (1) · Moderately (2) · Very (3) · Extremely characteristic of me (4). Indicate how characteristic each statement is of you.
1. I have difficulty making eye contact with others.
2. I find it difficult mixing comfortably with the people I work with.
3. I tense up if I meet an acquaintance in the street.
4. I have difficulty talking with other people.
5. I find it difficult to disagree with another's point of view.
6. I have difficulty thinking of things to say to people.
All four instruments (Mini-SPIN, SPIN, LSAS, SIAS-6) are validated screening tools, not diagnoses. Formal diagnosis of Social Anxiety Disorder (DSM-5 300.23 / ICD-10 F40.10) requires structured clinical interview by a qualified psychologist or psychiatrist, including differential diagnosis against avoidant personality disorder, autism spectrum disorder, body dysmorphic disorder, and other anxiety disorders. Cutoff scores are validated for research and clinical screening, not diagnostic confirmation. Your results here can inform your therapist but do not replace their assessment. If you are also experiencing thoughts of self-harm or suicide, please reach out for support today — contact your local emergency service, iCall (9152987821), Tele-MANAS (14416), or our care coordinator on WhatsApp.
Scores flagged something? Talk to a therapist today.
Same-day slots with licensed HopeQure psychologists.
Screen for what often travels with social anxiety.
Social anxiety disorder rarely comes alone — Kessler NCS-R found ~70% of adults with SAD develop another mental disorder in their lifetime. Once you've completed the primary SAD check-in (Mini-SPIN / SPIN / LSAS / SIAS-6), these five instruments screen the most common comorbidities and functional dimensions: DASS-21 (depression, general anxiety, stress — very common overlap), ISI (insomnia, often develops from anticipatory anxiety), AUDIT-C (alcohol use — up to 48% comorbidity with SAD as self-medication), PC-PTSD-5 (trauma often underlies SAD, especially early bullying), and ASRS (adult ADHD — often confused with SAD in adults, both cause interaction difficulty). Free, private, 60-120 seconds each.
🌐 About these instruments
All five scales below are published in peer-reviewed literature and used in clinical practice worldwide. Your scores are not stored server-side.
DASS-21 · Lovibond & LovibondISI · Morin / AASMAUDIT-C · WHOPC-PTSD-5 · US VA / NCPTSDASRS-v1.1 · WHO
DASS-21 · Depression Anxiety Stress Scales-21 · Lovibond & Lovibond (1995), University of New South Wales · Free to use. The DASS-21 is a 21-item short-form measuring three independent subscales — Depression (D), Anxiety (A), and Stress (S), 7 items each. Widely used in Australia, UK, Canada, and India for its clean separation of depression from anxiety from tension. Over the past week, how much did each statement apply to you?
Scale: Did not apply (0) · Some of the time (1) · Good part of the time (2) · Most of the time (3). Please answer all 21 items.
Depression items
1. I couldn\'t seem to experience any positive feeling at all
2. I found it difficult to work up the initiative to do things
3. I felt that I had nothing to look forward to
4. I felt down-hearted and blue
5. I was unable to become enthusiastic about anything
6. I felt I wasn\'t worth much as a person
7. I felt that life was meaningless
Anxiety items
8. I was aware of dryness of my mouth
9. I experienced breathing difficulty (rapid breathing, breathlessness in absence of exertion)
10. I experienced trembling (e.g. in the hands)
11. I was worried about situations in which I might panic and make a fool of myself
12. I felt I was close to panic
13. I was aware of the action of my heart in the absence of physical exertion
14. I felt scared without any good reason
Stress items
15. I found it hard to wind down
16. I tended to over-react to situations
17. I felt I was using a lot of nervous energy
18. I found myself getting agitated
19. I found it difficult to relax
20. I was intolerant of anything that kept me from getting on with what I was doing
21. I felt that I was rather touchy
ISI · Insomnia Severity Index · Morin 1993, Bastien et al. 2001 · The most-used sleep screener globally — recommended by the American Academy of Sleep Medicine (AASM) and used across sleep clinics worldwide. Insomnia is bidirectionally linked with depression, anxiety and stress — about 40% of insomnia patients meet criteria for a mental health disorder. Rate items based on the past 2 weeks.
1. Difficulty falling asleep
2. Difficulty staying asleep
3. Problem waking up too early
4. How satisfied / dissatisfied are you with your current sleep pattern?
5. How noticeable to others do you think your sleep problem is (in terms of impairing quality of life)?
6. How worried / distressed are you about your current sleep problem?
7. To what extent do you consider your sleep problem to interfere with daily functioning (fatigue, mood, work, concentration, memory)?
AUDIT-C · Alcohol Use Disorders Identification Test (Consumption) · Bush et al. 1998 · Adapted from WHO's AUDIT (Saunders 1993). The 3-item short-form used by WHO, CDC, and NHS for rapid alcohol-risk screening. Especially relevant for SAD: up to 48% of people with SAD also meet criteria for alcohol use disorder — most commonly as self-medication before social situations (Buckner et al. 2008). Untreated hazardous drinking substantially reduces CBT-SAD outcomes because it prevents proper exposure work — worth flagging honestly.
1. How often do you have a drink containing alcohol?
2. How many drinks on a typical day when you drink?
3. How often do you have 6 or more drinks on one occasion?
PC-PTSD-5 · Primary Care PTSD Screen for DSM-5 · Prins et al. 2016 · Published by the US National Center for PTSD (Veterans Affairs) · DSM-5 aligned. Especially relevant for SAD: childhood bullying, humiliation experiences, and social trauma are strongly linked to adult SAD onset. If a specific traumatic social experience underlies your SAD, trauma-focused CBT or EMDR alongside CBT-SAD may be needed — Wells & Papageorgiou (2001) work on trauma-linked SAD suggests better outcomes when both are treated. First, has anything ever happened to you that was so frightening, horrible, or upsetting it still bothers you? In the past month, have you:
1. Had nightmares about the event(s), or thought about the event(s) when you did not want to?
2. Tried hard not to think about the event(s), or gone out of your way to avoid reminders?
3. Been constantly on guard, watchful, or easily startled?
4. Felt numb, or detached from people, activities, or your surroundings?
5. Felt guilty, or unable to stop blaming yourself or others for the event(s) or its aftermath?
ASRS-v1.1 · Adult ADHD Self-Report Scale · WHO · Kessler, Adler, Ames et al. 2005 · Published by the World Health Organization as part of the World Mental Health Survey. The 6-item screener with strong sensitivity for adult ADHD. Especially relevant for SAD: adult ADHD is often mistaken for or comorbid with SAD — both can present as awkwardness, avoidance, and interaction difficulty. The mechanism is different (attention regulation vs fear of judgement) and treatment differs. If both are present, sequencing matters — usually ADHD treatment first. Over the past 6 months, how often:
1. Trouble wrapping up final details of a project once the challenging parts are done?
2. Difficulty getting things in order when you have to do a task requiring organisation?
3. Problems remembering appointments or obligations?
4. When you have a task requiring a lot of thought, avoid or delay getting started?
5. Fidget or squirm with hands or feet when you have to sit down for a long time?
6. Feel overly active and compelled to do things, as if driven by a motor?
All five instruments are screening tools, not diagnoses. Any positive screen — especially for suicidality (PHQ-9 item 9), heavy drinking, or PTSD — warrants prompt discussion with a qualified clinician. If you are in crisis, contact your local emergency service or a crisis helpline immediately.
Multiple positive screens? A full evaluation ties it together.
If two or more of the above flagged, a comprehensive evaluation can map your full picture, screen for what wasn't captured, and match you to the right combination of therapy and (if indicated) medication. ₹4,999 all-in.
Six quick questions about your social anxiety pattern and how you naturally work. Your answers map to the six evidence-based SAD approaches — Clark & Wells individual CBT · Heimberg group CBT · ACT for SAD · Metacognitive Therapy · Combined CBT+SSRI · Attention Training Technique — so you can match with a therapist whose approach fits your presentation. Takes 90 seconds.
Question 1 of 6
Question 1Which best describes when your social anxiety hits you?
Question 2What's the most bothersome part of your social anxiety?
Question 3How much structure do you want from CBT-SAD?
Question 4What's your relationship with your social-anxious thoughts?
Question 5What's currently making your SAD worse?
Question 6What are you open to trying between sessions?
Question 1 of 6
CBT-SAD modality guidance is derived from published SAD-specific frameworks — Clark & Wells (1995, Oxford), Heimberg (Temple), Wells (Manchester Metacognitive Therapy), Dalrymple & Herbert / Kocovski (ACT for SAD), Blanco et al. (combined treatment). This is an educational match tool, not a substitute for clinical assessment — your CBT-SAD therapist will refine and integrate approaches to your presentation.
Which Path Is Right for You?
Treatment paths, side by side.
Mayo-Wilson et al. (2014) Lancet Psychiatry network meta-analysis of 101 SAD trials with 13,164 participants gives the clearest picture: individual CBT-SAD produced the largest effects, followed by combined CBT+SSRI (best for severe), then SSRI monotherapy, then guided iCBT-SAD self-help. Here is how the four main paths compare on the metrics that matter for social anxiety specifically.
Compare on
CBT-SAD Alone (Clark & Wells)
Combined CBT-SAD + SSRI
SSRI Alone
Guided iCBT-SAD Self-Help
Effect size on core SAD symptoms
Largest (SMD -1.19 · Mayo-Wilson 2014)
Best for severe (SMD -1.30 · Blanco 2010)
Moderate (SMD -0.65 · Mayo-Wilson 2014)
Moderate (g=0.84 · Kampmann 2016)
Best fit profile
Mild-to-moderate SAD (LSAS <80), most presentations, no severe comorbidity
Severe SAD (LSAS >80), SAD + depression, treatment-resistant
SAD when CBT unavailable or refused; comorbid depression as add-on
Mild SAD, wait-list adjunct, geographic barriers
Time to visible improvement
4-8 weeks (early exposure gains)
2-4 weeks (SSRI) + 4-8 weeks (CBT-SAD)
6-12 weeks (SSRI titration for SAD is slower)
8-12 weeks with therapist guidance
Skills built (last beyond treatment)
High — Clark & Wells 8 skills, exposure toolkit
High — skills + biological support
Low — symptom suppression only, high relapse on stop
Modest — depends on completion (Karyotaki attrition ~50%)
Ongoing effort required
Moderate (weekly + practice)
Moderate
Low (daily pill)
Self-driven — attrition is high (Karyotaki 2017)
Side effects
None
Medication-related
SSRI / SNRI side effects (nausea, libido, sleep)
None
Monthly cost (India, approx.)
₹4,000-8,000
₹5,500-10,000
₹1,500-4,000
₹0-500
Long-term durability (3-5 yr)
Excellent — Andrews 2018: gains maintained
Excellent (CBT skills persist even after SSRI stop)
Poor — 60-70% relapse within 6 months of SSRI stop
Modest — Karyotaki 2018 shows durability with completers
Sustainability if treatment stops
Skills persist for years
Skills persist; some symptoms may return without med
Symptoms return within weeks
Habits fade without accountability
Effect sizes from Mayo-Wilson et al. (2014) Lancet Psychiatry network meta-analysis of 101 SAD trials (n=13,164), Blanco et al. (2010, 2013) combined-treatment RCTs, Kampmann et al. (2016) iCBT-SAD meta, Andrews et al. (2018) long-term follow-up, Cipriani et al. (2018) SSRI network meta. Costs are illustrative ranges based on HopeQure pricing; actual costs vary by session frequency, medication choice, and local pharmacy pricing.
If Medication Is Considered for SAD · Full Class Comparison
Understanding SAD medication, without the jargon.
Medication is used selectively in SAD — mild-to-moderate cases usually respond to Clark & Wells CBT alone. Medication is added when SAD is severe (LSAS >80), when comorbid depression is significant, when CBT alone has plateaued, or when performance situations need immediate physiological support. Three classes matter: SSRIs (first-line, FDA-approved for SAD), SNRIs (venlafaxine XR, FDA-approved for SAD), and situational beta-blockers (propranolol for performance SAD only). Benzodiazepines are avoided in SAD because they interfere with CBT exposure work. All prescriptions require video consultation with a registered psychiatrist and periodic monitoring.
SSRIs for SAD (Paroxetine · Sertraline · Escitalopram · Fluvoxamine)
Selective Serotonin Reuptake Inhibitor · Prescription · First-line class for SAD
How it works
Increase serotonin availability at the synapse over 4-8 weeks. Reduce the amygdala hyper-reactivity to social threat cues observed in SAD (Furmark et al. neuroimaging studies).
FDA approvals for SAD
Paroxetine (1999, first), sertraline (2003), fluvoxamine CR (2008). Escitalopram widely used off-label with strong RCT support.
Duration
Once-daily · SAD titration is slower than for depression · steady-state 4-8 weeks · continue 12+ months after remission (longer than depression)
Effect on SAD
Moderate effect (SMD -0.65, Mayo-Wilson 2014). Response rates 50-70% at 12 weeks. Combined with CBT-SAD outperforms either alone for severe SAD (Blanco 2010).
Common side effects
Nausea (first weeks), sexual side effects, initial activation or drowsiness, sleep changes, weight changes over months. Paroxetine has the worst discontinuation syndrome.
Monitoring needed
Suicidality (boxed warning in under-25s), initial activation, LSAS/SPIN at baseline and every 4-6 weeks. Serotonin syndrome risk with tramadol, triptans, MAOIs.
Typical monthly cost
₹150-800 (generics widely available in India — sertraline, escitalopram, paroxetine)
Best when
Moderate-severe SAD (SPIN >30 or LSAS >55), SAD + depression, SAD + panic, or CBT alone has plateaued. Sertraline safest in pregnancy per NICE.
SNRIs for SAD (Venlafaxine XR)
Serotonin-Norepinephrine Reuptake Inhibitor · Prescription · FDA-approved for SAD (2003)
How it works
Increases both serotonin AND norepinephrine. Slightly different mechanism from SSRIs; some patients respond to venlafaxine after SSRI non-response.
FDA approval for SAD
Venlafaxine XR — 2003 FDA approval specifically for generalised SAD (Liebowitz 2005 RCT)
Duration
Daily · 4-8 weeks to full effect · avoid abrupt discontinuation (venlafaxine especially — significant discontinuation syndrome)
Effect on SAD
Comparable to SSRIs for SAD (Liebowitz 2005). Often chosen when SSRI has failed or when comorbid GAD/pain is a factor.
Common side effects
Nausea, dry mouth, sweating, blood pressure elevation (dose-dependent, especially at >150 mg), insomnia. BP monitoring important.
Monitoring needed
Blood pressure at baseline + every 4-6 weeks, discontinuation planning (very slow taper), same suicidality monitoring as SSRIs
Typical monthly cost
₹250-1,500 (XR formulation is pricier than immediate release but essential for SAD)
Best when
SSRI non-response for SAD, SAD + GAD, SAD + chronic pain, patient preference for once-daily XR formulation
Situational Beta-Blockers (Propranolol for Performance SAD only)
Non-selective beta-adrenergic blocker · Prescription · For discrete performance situations only
How it works
Blocks peripheral adrenergic receptors. Reduces the physical symptoms of performance anxiety — hand tremor, voice tremor, palpitations, sweating — without affecting cognition or causing sedation.
Typical use
10-40 mg PRN, taken 45-60 min before a specific performance (presentation, viva, recital, viva-voce, defense). NOT taken daily.
Duration
Onset 30-45 min · duration 3-6 hours · single-dose PRN use only
Effect on SAD
Strong for the physical component of performance SAD. Used by musicians, actors, teachers, lawyers, surgeons for decades. Does NOT treat generalised SAD.
Common side effects
Fatigue, cold hands/feet, slow heart rate, occasional dizziness on standing. Well-tolerated for occasional use.
Contraindications
Asthma, COPD, bradycardia, heart block, uncontrolled diabetes (masks hypoglycaemia awareness). Requires cardiovascular history at prescribing.
Typical cost
₹80-200 per 10-tablet strip (generic widely available)
Best when
Performance-only SAD (public speaking, exams, viva, recital, sports). Used as PRN adjunct alongside CBT-SAD focused on performance situations. NOT for generalised SAD.
⚠ Why benzodiazepines are avoided in SAD: Alprazolam, lorazepam, clonazepam and other benzodiazepines reduce acute anxiety BUT they interfere with the exposure-based learning that CBT-SAD requires — the brain never fully learns "this situation is safe" because the fear response was pharmacologically blunted. They also carry dependence and cognitive side-effect risks. Per NICE CG159 and APA guidelines, benzodiazepines should NOT be used for routine SAD management. Situational propranolol for performance is the safer physiological support. All prescriptions require registered psychiatrist evaluation.
The HopeQure Philosophy for SAD
Social anxiety rarely travels alone.
Roughly 70% of people with SAD develop another mental disorder in their lifetime (Kessler NCS-R). Depression is the most common companion, followed by alcohol use disorder as self-medication, then panic and generalised anxiety. Treating SAD in isolation while missing these comorbidities usually stalls treatment. HopeQure CBT-SAD evaluations screen the full picture, then sequence care accordingly.
~70%Any lifetime comorbidity
~50%SAD + Depression
~48%SAD + Alcohol use
~30%SAD + Panic disorder
~28%SAD + GAD
~40%SAD + Avoidant PD
~20%SAD + Adult ADHD
15 yrsAverage delay to treatment
Comorbidity rates from Kessler NCS-R (2005), Buckner et al. 2008 (SAD + alcohol), Wittchen et al. 1999 (SAD onset & delay), Ruscio et al. 2008 (SAD lifetime prevalence). Your CBT-SAD evaluation includes structured screening across all of these.
The Six Most Common SAD Combinations We See
One social anxiety diagnosis, often several layers.
Because ~70% of people with SAD carry another disorder in their lifetime, treating social anxiety in isolation often stalls. Here are the six combinations we see most often — and the specific sequenced approach for each.
🌧
SAD + Depression
~50% comorbidity
Depression often develops after years of SAD-driven avoidance shrinks life opportunities. Untreated depression predicts poorer SAD outcomes; SAD + depression can be more disabling than either alone. Both respond well to SSRIs and to CBT with modifications.
Integrated care plan: PHQ-9 + SPIN at baseline · If depression moderate-severe, stabilise first · SSRI (sertraline, escitalopram) treats both · CBT-SAD + behavioural activation module · Watch for suicidal ideation particularly during initial SSRI weeks
🥃
SAD + Alcohol Use
~48% comorbidity
Alcohol is often used to "get through" social situations — parties, dating, workplace events. Over time this becomes established self-medication and can develop into alcohol use disorder. Blocks the CBT-SAD exposure work — the fear never fully disconfirms if you were slightly buzzed the whole time (Buckner 2008).
Integrated care plan: AUDIT-C + SPIN at baseline · Motivational interviewing for alcohol goals · Reduce or stop alcohol before intensive exposure work · CBT-SAD adapted with sober-exposure planning · Coordinated with addiction specialist if severe · SSRIs still usable but sertraline preferred
💥
SAD + Panic Disorder
~30% comorbidity
Panic attacks specifically in feared social situations, sometimes generalising to unexpected attacks. Requires differentiation: is the fear of the panic itself (panic disorder) or of the social embarrassment (SAD)? Usually both. Panic-specific interoceptive exposure adds to standard CBT-SAD.
Integrated care plan: SPIN + panic attack log · Barlow-style panic-specific interoceptive exposure alongside CBT-SAD · SSRI (paroxetine or sertraline) treats both · Avoid benzodiazepines (interfere with exposure) · Address anticipatory anxiety pattern common to both
🌊
SAD + Generalised Anxiety Disorder
~28% comorbidity
Worry beyond just social contexts — health, finances, work, family. Distinct diagnosis from SAD but often layered on top. Cognitive style (rumination) overlaps significantly; MCT often works well for the combination since it targets the meta-worry underlying both.
Integrated care plan: SPIN + GAD-7 + PSWQ at baseline · Metacognitive Therapy (Wells) often best fit — targets both · SSRI/SNRI (escitalopram, venlafaxine XR) treats both · CBT-SAD adapted with worry-postponement module · Watch for shift between primary worry topics
🕳
SAD + Avoidant Personality Disorder
~40% overlap
The differential is difficult and clinically important. AvPD is a pervasive lifelong pattern of feeling inadequate and avoiding relationships even where wanted — beyond fear alone. Severe generalised SAD and AvPD share many features. Treatment is similar but AvPD typically needs longer-term work.
Integrated care plan: Structured clinical interview at evaluation · Schema-focused CBT or MBT if AvPD confirmed · Longer treatment course (20-30 sessions) · Focus on core beliefs of inadequacy in addition to standard CBT-SAD · SSRI can still help
🎯
SAD + Adult ADHD
~20% overlap
Often confused with SAD because both cause interaction difficulty, but the mechanism is different: SAD is fear-driven, ADHD-related social difficulty is attention/impulse-driven. Both can coexist. Untreated ADHD can look like "social anxiety" that never responds to CBT-SAD.
Integrated care plan: ASRS + SPIN + full ADHD evaluation · Usually ADHD treatment first (stimulant or atomoxetine) — social difficulty often improves substantially · Then CBT-SAD if residual social fear persists · Executive-function coaching integrated · Coordinate psychiatrist + psychologist
Want a plan mapped to your profile? Build one in 60 seconds.
Our AI Care Roadmap Builder maps your specific presentation to an evidence-based therapy + medication mix, timeline, and budget estimate. No sign-up needed.
Build your personalised CBT-SAD roadmap in 60 seconds.
Answer 5 quick questions. Our AI cross-references NICE CG159 (Social Anxiety Disorder) + Mayo-Wilson 2014 Lancet Psychiatry network meta-analysis + Clark & Wells cognitive model + Heimberg group CBT protocol + Blanco combined-treatment RCT evidence with your specific SAD profile to generate a recommended CBT-SAD approach, expected timeline, and budget estimate. This is guidance, not diagnosis — but it's a great starting point for a conversation with our CBT-SAD clinicians.
1Age band
→
2Primary concern
→
3Severity
→
4Companions
→
5Budget
What\'s your age range?
Modality choice and provider match differ across life stages.
What's your social anxiety pattern?
From your Mini-SPIN/LSAS results or your own sense of it. Pick the closest fit.
How much is it affecting daily life?
Severity guides intensity of intervention. Be honest — this is confidential.
Any co-occurring concerns?
Tick all that apply. ~70% of people with SAD have at least one comorbidity — this shapes sequencing.
What\'s a comfortable monthly budget?
We can build a good plan at every level — this just helps us pick the right intensity.
This tool provides evidence-based guidance from APA Division 12 · NICE · WHO mhGAP · APA telepsychology guidelines — not a medical diagnosis. Only a qualified, licensed clinical psychologist or registered psychiatrist can diagnose after proper evaluation.
Transparent Cost Planning
Total cost of care calculator.
Estimate your monthly and annual spend on CBT-SAD care. Adjust the sliders to see how session frequency, psychiatric SSRI review, and group CBT programme options affect the total. No hidden costs — everything you'd pay HopeQure is included.
Adjust your care mix
Your estimated monthly cost
CBT-SAD sessions₹3,996
Psychiatrist SSRI review₹499
Medication (est.)₹0
Group CBT-SAD add-on₹0
Attention training add-on₹0
Estimated Total
₹4,495/mo
Annual estimate: ₹53,940 · Or bundle in our 12-session CBT-SAD programme at ₹9,999 for the first quarter (~40% savings)
Estimates based on HopeQure standard pricing. Actual costs vary by expert selected and care intensity. Medication costs are external (pharmacy) and vary by formulation.
Book Your First Session · WELCOME10 · 10% OFF
Ready to start? Pick the path that fits you.
28 CBT-SAD specialists online right now · Book by chat if calling feels hard · First session ₹999 with code WELCOME10
⚡ FASTEST
📅
Instant Book
Browse therapists, pick a slot, pay — booked in 90 seconds. Same-day slots available.
✓ From ₹999 with WELCOME10
✓ Same-day slots
✓ Free therapist swap after session 1
🔒 ISO 27001 · HIPAA · GDPR💳 Secure Razorpay · Stripe payments🌍 Sessions delivered in 40+ countries
Your CBT-SAD Journey · What Happens When
From first click to durable recovery.
Because booking itself can trigger social anxiety, we've designed the journey
to be maximally low-friction — chat-only booking is welcome, no phone call
needed to start. Here's exactly what to expect at each stage.
1
First Contact · Chat, WhatsApp or Callback
◷Timing:
Same day.
▤Format:
Text-only OK.
Message us on WhatsApp, request a callback, or book directly through
the widget. No lengthy forms. We ask three things: are you looking
for yourself or someone else, roughly what's going on (a line is
enough), and when you'd like your first session. If you'd rather book
by chat and skip the intro call entirely, that's standard for our
SAD clients — just tell us.
2
SAD-Focused Evaluation (Session 1)
◷Timing:
Week 1-2.
⌛Duration:
60-90 min.
₹Cost:
₹4,999
Full clinical interview with your CBT-SAD-trained psychologist.
Complete LSAS (24 items with fear and avoidance), SPIN, SIAS-6,
and BFNE for baseline SAD severity. Comorbidity screens: PHQ-9,
GAD-7, AUDIT-C, PC-PTSD-5 as indicated. Clark & Wells case
formulation — a written map of YOUR specific maintaining factors
(which safety behaviours, which attention pattern, which negative
self-image content). Personalised CBT-SAD plan.
3
Active CBT-SAD Treatment
◷Timing:
Weeks 2-16.
▣Frequency:
Weekly.
⌛Duration:
50 min each.
Weekly Clark & Wells CBT-SAD sessions. Sessions 1-3
psychoeducation + cognitive model + safety-behaviour mapping.
Sessions 4-8 video-feedback + attention refocus training + first
behavioural experiments. Sessions 9-14 systematic graded exposure
hierarchy. Between sessions: behavioural experiments in real-world
settings, video-feedback review, safety-behaviour drops.
LSAS/SPIN rescoring at session 4, 8, 12.
4
Consolidation & Long-Term Maintenance
◷Timing:
Month 4+.
▣Frequency:
Monthly then as-needed.
Relapse-prevention blueprint (your written maintenance plan).
Session frequency drops to fortnightly then monthly. Occasional
booster sessions for high-stakes situations (new job interviews,
big presentations, life transitions). If SSRI was used, continue
12 months minimum after remission then taper with psychiatrist.
Andrews 2018: CBT-SAD gains are maintained at 3-5 year follow-up —
unlike medication, there is no post-discontinuation relapse.
Support Beyond the Session
The support system around your CBT-SAD.
Social anxiety often makes reaching out hardest exactly when it's most needed.
HopeQure surrounds your active CBT-SAD with two layers of between-session support
so you never have to wait a week to get unstuck.
EMPLOYER SUPPORT
Employer EAP Coverage for SAD
Many employers now include social anxiety CBT under their Employee
Assistance Programme (EAP). If your company works with HopeQure or
Prime EAP (our corporate wellness arm), your CBT-SAD sessions may be
fully or partially covered — no cost to you, and you don't need to tell
your employer what it's for. Sessions can be scheduled in evenings or
lunch breaks; complete confidentiality between HopeQure and your employer
is contractually guaranteed. Ask your HR whether HopeQure/Prime EAP is
available, or WhatsApp us and we'll check for you.
Active CBT-SAD requires between-session practice — behavioural experiments
in real social situations, safety-behaviour drops, video-feedback review,
post-event processing interruption. This is where change actually happens,
and it's also where people get stuck. Your therapist is reachable by chat
between sessions for quick check-ins (e.g. "I'm about to do my first
behavioural experiment and I'm panicking — reassure me?"). We also provide
the digital tools: exposure hierarchy builder, thought record templates,
safety-behaviour log, post-event processing worksheet, all accessible in
the app.
Not every therapist is a CBT-SAD specialist. Here are the five things that actually predict a good outcome — worth checking whether you book with HopeQure or elsewhere.
🎓 CBT-SAD Credentials
🧠 Approach Fit
🤝 Therapeutic Alliance
📅 Practical Fit
⭐ Track Record
🎓 CBT-SAD Credentials — the floor, not the ceiling
Foundational qualification: M.Phil Clinical Psychology (RCI-licensed), M.A. Clinical Psychology, or MBBS + MD Psychiatry. This is the baseline.
Specific CBT-SAD training: Look for Clark & Wells CBT-SAD supervision, Heimberg CBGT training, or equivalent SAD-focused CBT training beyond general CBT.
Exposure supervision: Trained to conduct in vivo behavioural experiments and graded exposure work with SAD clients — not all CBT therapists have this.
Continuing education in SAD: Post-2015 training in Clark & Wells updates, MCT for SAD (Wells), or ACT for SAD (Kocovski) is a strong signal.
Ask specifically: "Have you completed Clark & Wells CBT-SAD training or supervision?" Every credible CBT-SAD therapist welcomes this question.
HopeQure verifies every therapist — credentials, licensing, background check, and specifically for CBT-SAD-trained therapists we require documented supervision.
Why it's the floor, not the ceiling: Credentials tell you the therapist has met a minimum standard — they do not, on their own, predict whether you'll do well with them for SAD specifically. The next four items do.
🧠 Approach Fit — CBT-SAD technique aligned to your presentation
Match approach to your SAD subtype: Clark & Wells individual CBT for generalised SAD; Heimberg group CBGT if you prefer peer-based; ATT + focused CBT for performance-only; combined CBT + SSRI for severe.
Match approach to how you work best: Some thrive on structure and worksheets (Clark & Wells); others need acceptance-based (ACT for SAD); others need meta-level rumination work (MCT).
Most experienced CBT-SAD therapists are integrative — they anchor in one protocol but flexibly draw from others. Ask what their primary framework is.
Take our CBT-SAD Approach Match Quiz above for a starting point on which CBT-SAD approach fits how you naturally process.
Not sure yet? The CBT-SAD Evaluation matches you with the right approach after proper assessment, rather than guessing upfront.
What the research says: For SAD specifically, approach choice matters MORE than for many conditions — Clark & Wells CBT produces meaningfully larger effect sizes than generic CBT (Mayo-Wilson 2014). Getting the right protocol matters.
🤝 Therapeutic Alliance — the biggest predictor of CBT-SAD outcome
Do you feel understood? After session 1-2, do you feel this person actually gets the specific texture of your social anxiety? If not, that's data — not a failure.
Do you feel safe enough to be honest? SAD makes this specifically hard. A CBT-SAD therapist actively works to reduce that barrier — asks whether video is OK, offers chat option, no cameras until you're ready.
Do you agree on the exposures? If you're asked to do behavioural experiments you don't buy into or that feel unsafe, name that. A good CBT-SAD therapist adjusts collaboratively.
Feel comfortable disagreeing? The willingness to push back — and have that received without defensiveness — is the alliance in action.
Trust your gut over 3 sessions — not one bad session, but a settled sense of "I don't connect here" is worth acting on.
What the research says: Alliance quality accounts for 5-15% of outcome variance across studies (Horvath & Del Re meta-analyses). HopeQure offers a free therapist swap after session 1 if the fit isn't right, no explanation needed.
📅 Practical Fit — the things that make CBT-SAD sustainable
Language: CBT-SAD in your first language is meaningfully more effective — you can access emotion and describe safety behaviours more precisely. HopeQure offers 15+ Indian languages plus English.
Format: Video is default for CBT-SAD (needed for video-feedback exercises) but audio-only or chat is available for early sessions if social anxiety makes camera hard at first.
Time zone / availability: Weekly consistency matters more than session length. Pick a slot you can genuinely hold across the 14-16 week Clark & Wells protocol.
Session frequency: Weekly is standard for active CBT-SAD; fortnightly for consolidation; monthly for maintenance.
Cost: A CBT-SAD therapist you can afford weekly is better than a "top" one you can only afford monthly. Consistency matters more than prestige — the 12-week programme (₹9,999) or Heimberg group (₹6,999) may be more sustainable.
Cultural fit: Preferences around gender, age, cultural background are legitimate — especially for SAD where feeling judged is the core fear.
Why this matters more than people expect for SAD: Attrition — dropping out of CBT-SAD early, especially before behavioural experiments start — is the biggest silent killer of good outcomes. Practical fit predicts whether you actually complete the protocol.
⭐ Reviews, Reputation & SAD Track Record
Read reviews carefully: Look for reviews mentioning SAD, social anxiety, shyness, or performance anxiety specifically. Look for patterns.
Look for CBT-SAD experience: Years of general practice matter, but so does SAD-specific caseload. A therapist who sees 30% SAD clients is different from one who sees 5%.
Ask about outcomes: Good CBT-SAD therapists routinely measure outcomes with LSAS/SPIN/SIAS-6 every 4-6 sessions. Ask if they do.
Ask about complexity: "Have you worked with clients who present with [performance SAD / severe generalised SAD / SAD+depression]?" — most therapists will be direct if they have.
HopeQure CBT-SAD therapist averages: 4.5/5 rating across our SAD-specific caseload. All ratings public. Match guarantee — swap after session 1 at no cost if fit isn't right.
The one-session test: After session 1, ask yourself — did I feel heard? Do I trust their competence with SAD specifically? Am I willing to do the CBT-SAD work with them? If yes to all three, stay. If not, swap. It's not personal.
Free 15-min match call (chat OK) · First-session guarantee · 28 CBT-SAD specialists across every approach
Common Beliefs About Social Anxiety
Eight SAD myths, gently corrected.
Social anxiety is one of the most misunderstood mental health conditions — commonly written off as just shyness or introversion when it's actually a treatable clinical disorder affecting 7-12% of adults lifetime. Here are eight of the most-common myths we hear, and what the research actually shows.
Myth
"Social anxiety is just shyness — everyone has it a bit."
Fact
Shyness is a temperament trait; SAD is a clinical disorder with specific DSM-5 criteria (300.23) and specific neurobiology (amygdala hyper-reactivity, reduced ventromedial prefrontal regulation). 7-12% of adults meet full SAD criteria lifetime (Kessler NCS-R). Untreated, it strongly predicts depression, alcohol use disorder, and suicide risk.
Myth
"Exposure therapy is retraumatising — being forced into feared situations."
Fact
Modern CBT-SAD uses collaborative graded exposure with behavioural experiments — you choose each step, you set the pace, nothing is forced. The evidence is unambiguous: exposure-based CBT produces the largest effect sizes of any SAD treatment (Mayo-Wilson 2014). Avoidance is what maintains the disorder; carefully-designed exposure is what dismantles it.
Myth
"If I start SSRIs for SAD, I'll be on them forever."
Fact
Guidelines recommend 12 months minimum after remission for SAD (longer than for depression), then a slow taper. Many people successfully stop after 12-18 months if they had CBT-SAD alongside — the CBT skills continue to work after the medication stops. Some people choose to continue long-term for stability; that's a valid choice but not required.
Myth
"CBT is cold and formulaic — just worksheets and techniques."
Fact
Modern CBT-SAD (especially Clark & Wells) is highly personalised — your specific safety behaviours, your specific negative self-image, your specific feared predictions. Video-feedback and behavioural experiments are creative, sometimes even fun. Wampold's research shows the therapeutic alliance matters as much as the technique — CBT-SAD therapists are trained in both.
Myth
"I'm too extroverted / senior / successful to have social anxiety."
Fact
SAD affects people across every personality type, career level, and life stage. Many high-performing lawyers, doctors, executives, musicians, and public figures have SAD — often mask it well but suffer significantly, and often turn to alcohol. Being "good in a crowd" doesn't rule out SAD. What matters is whether specific situations trigger disproportionate fear and life-restricting avoidance.
Myth
"I should be able to fix this myself — I'm an adult."
Fact
SAD has a specific maintaining mechanism (Clark & Wells 4-factor model) that's counterintuitive to see from the inside — self-focused attention, safety behaviours, distorted self-image, post-event rumination all feel like they're helping when they're actually maintaining the fear. This is why average delay to treatment is 15 years, and why once people get proper CBT-SAD, they typically wonder why they waited so long.
Myth
"Alcohol / weed helps my social anxiety — that's a coping tool."
Fact
Alcohol/cannabis provides short-term relief but strongly reinforces avoidance and prevents disconfirmation of feared predictions (Buckner 2008). Up to 48% of people with SAD develop alcohol use disorder — the self-medication pattern is the entry point. Reducing or stopping the substance is usually needed before CBT-SAD exposure can work properly.
Myth
"I'll be judged by the therapist too — I can't even do therapy."
Fact
The whole point of a CBT-SAD therapist is that they've spent their career specifically studying and treating this fear. Nothing you describe will shock or judge them — social anxiety patterns are their daily work. HopeQure allows chat-only booking, chat-only first session if you prefer, no cameras until you're ready. Your therapist wants you to succeed and knows exactly how to make the process safe.
Social Anxiety at Global Scale
Just how common and treatable SAD really is.
Social anxiety disorder is the third-most common mental health condition worldwide, behind only depression and specific phobia. Despite that, average delay to treatment is 15+ years — mostly because SAD itself makes seeking help feel dangerous. The numbers below are worth knowing: this is not a niche problem, and it's not a treatment-resistant one.
7-12%
Lifetime prevalence (adults)
Kessler NCS-R 2005, WHO WMH Surveys — 3rd most common mental disorder
11-15 yrs
Peak age of onset
Wittchen et al. 1999, Kessler NCS-R — often mistaken for "just shyness"
15 yrs
Average delay to treatment
Wang et al. 2005 Arch Gen Psychiatry — the longest delay of any anxiety disorder
~70%
Develop another disorder
Kessler NCS-R — most often depression, alcohol use, panic
SMD -1.19
Effect size of individual CBT-SAD
Mayo-Wilson 2014 Lancet Psychiatry — largest of any SAD intervention
55-70%
CBT-SAD recovery rate
Clark et al. 2003-2016 Oxford RCTs · meaningful improvement in 80%+
3-5 yrs
Durability of CBT-SAD gains
Andrews et al. 2018 — no post-treatment relapse, unlike medication
g=0.84
Effect of online CBT-SAD
Kampmann et al. 2016 meta — internet-delivered matches face-to-face
Sources: Kessler et al. National Comorbidity Survey Replication (NCS-R) 2005 · Wittchen et al. Community-based epidemiology of SAD onset (1999) · Wang et al. Delays in initial treatment contact (2005) · Mayo-Wilson et al. Psychological and pharmacological interventions for SAD network meta-analysis (Lancet Psychiatry 2014) · Kampmann et al. Meta-analysis of technology-assisted interventions for SAD (2016) · Andrews et al. Computer therapy for anxiety and depression is effective (PLoS ONE 2018) · NICE Clinical Guideline CG159 Social Anxiety Disorder (2013).
The Complete SAD Assessment Toolkit
Every validated SAD instrument · what they measure, what they cost, what we use.
A structured SAD evaluation is not one questionnaire — it's a targeted battery of validated instruments that triangulate SAD severity, situational specificity, cognitive processes, safety behaviours, and comorbidity. Here's the full landscape of SAD-specific and adjacent instruments: which are free, which are proprietary, what each is best for, and which ones your HopeQure CBT-SAD evaluation actually uses.
← swipe table sideways to see all columns →
Instrument
Measures
Ages · Items
Rater
Cost
Evidence base
We use it
LSAS-SR(Liebowitz Social Anxiety Scale - Self-Report)
SAD severity across 24 situations (13 performance, 11 interaction) · fear AND avoidance ratings · standard for RCTs
16+ · 24 items × 2
Self-report
Free (self-report version)
Liebowitz 1987 · Fresco 2001 · gold-standard SAD outcome measure
Core SAD
SPIN(Social Phobia Inventory)
SAD severity across 17 items covering fear, avoidance, physiological symptoms · cutoff ≥19 for SAD diagnosis
13+ · 17 items
Self-report
Free · Connor
Connor et al. 2000 Br J Psychiatry · widely validated
Core SAD
Mini-SPIN(Mini Social Phobia Inventory)
Quick SAD screener · 3 items from SPIN · cutoff ≥6 for likely SAD · 30-second administration
13+ · 3 items
Self-report
Free · Connor
Connor et al. 2001 · sensitivity 89%, specificity 90%
Screening
SIAS / SIAS-6(Social Interaction Anxiety Scale)
Specifically social interaction anxiety (distinct from performance) · SIAS-6 short form · cutoff ≥7
16+ · 20 or 6 items
Self-report
Free · Mattick & Clarke
Mattick & Clarke 1998 · Peters 2012 (SIAS-6)
Core SAD
SPS(Social Phobia Scale)
Performance/observation-specific SAD (being watched, scrutinised) · companion to SIAS
16+ · 20 items
Self-report
Free · Mattick & Clarke
Mattick & Clarke 1998 · often used with SIAS
Performance-focused cases
BFNE(Brief Fear of Negative Evaluation Scale)
Core SAD cognitive process: fear of being judged negatively · key mediator of CBT-SAD outcome
16+ · 12 items
Self-report
Free · Leary
Leary 1983 · Rodebaugh 2004 (BFNE-II)
Core SAD
PSWQ(Penn State Worry Questionnaire)
Trait worry — distinguishes GAD-type worry from SAD-type post-event rumination
18+ · 16 items
Self-report
Free · Meyer
Meyer et al. 1990 · gold standard for worry
SAD+GAD differential
PEPQ(Post-Event Processing Questionnaire)
Post-event rumination specific to SAD · quantifies the mental replay after social situations
Clark & Wells 1995 · core to CBT-SAD case formulation
CBT-SAD formulation
PHQ-9(Patient Health Questionnaire-9)
Depression comorbidity screen (~50% of SAD cases have comorbid depression)
13+ · 9 items
Self-report
Free · Pfizer / WHO
Kroenke, Spitzer & Williams 2001
Comorbidity
GAD-7(Generalized Anxiety Disorder-7)
Generalised anxiety comorbidity screen (~28% of SAD cases have GAD)
13+ · 7 items
Self-report
Free · WHO
Spitzer et al. 2006
Comorbidity
AUDIT-C(Alcohol Use Identification Test - Short)
Alcohol use as self-medication for SAD (~48% of SAD cases develop alcohol issues)
18+ · 3 items
Self-report
Free · WHO
Bush et al. 1998 · Buckner 2008 (SAD-specific)
Comorbidity
PC-PTSD-5(Primary Care PTSD Screen)
Screens for trauma history often linked to SAD (childhood bullying, social humiliation)
18+ · 5 items
Self-report
Free · US NCPTSD
Prins et al. 2016
Comorbidity
ASRS-v1.1(Adult ADHD Self-Report Scale)
ADHD differential (~20% overlap; ADHD-driven social difficulty often mimics SAD)
18+ · 6 items
Self-report
Free · WHO
Kessler et al. 2005
Differential diagnosis
The Core SAD instruments (LSAS, SPIN, SIAS-6, BFNE) run in every HopeQure CBT-SAD evaluation. CBT-SAD tracking instruments (PEPQ, SBQ) are used across active treatment for personalised case formulation. Comorbidity screens (PHQ-9, GAD-7, AUDIT-C, PC-PTSD-5) are added because ~70% of SAD cases have at least one comorbidity. Mini-SPIN is used for rapid screening. Differential instruments (ASRS, PSWQ) rule in/out related conditions.
Long-Term SAD Outcomes · What Research Tells Us
The evidence that CBT-SAD changes lives.
Beyond short-term SPIN/LSAS reduction, does CBT-SAD actually change long-term life outcomes? Longitudinal SAD-specific studies and meta-analyses answer this — for symptom durability, comorbidity, alcohol use, career trajectory, and relapse prevention.
🏆
Durability of CBT-SAD gains (3-5 yr)
Unlike SSRI treatment (60-70% relapse within 6 months of discontinuation), CBT-SAD gains are maintained at 3-5 year follow-up in the majority of completers. The skills continue to compound over time.
Andrews et al. 2018 PLoS ONE · Clark et al. long-term follow-up 2003-2016 · Powers 2008 meta.
📉
Recovery vs response rates
Clark & Wells CBT-SAD produces recovery (return to healthy functioning) in 55-70% of patients, response (meaningful improvement) in 80%+. Mayo-Wilson 2014 network meta: SMD -1.19, the largest of any SAD intervention.
Mayo-Wilson 2014 Lancet Psychiatry · Clark et al. RCT series · Ougrin 2011 meta.
🍷
Reduced alcohol self-medication
Successful CBT-SAD reduces the need for alcohol as social "lubricant." Meta-analyses show significant reduction in alcohol-use frequency and quantity following CBT-SAD, particularly in early adulthood cohorts.
Buckner et al. 2008 Clin Psychol Rev · Book & Randall 2002 · Randall et al. 2001.
💼
Career & income trajectory
Untreated SAD is associated with lower educational attainment, career under-achievement, and lower lifetime income (Katzelnick 2001 estimated $2,300/year lower earnings per person with SAD). Treatment reverses this trajectory.
Katzelnick et al. 2001 Am J Psychiatry · Wittchen & Beloch 1996 · Mendlowicz & Stein 2000.
💊
Combined treatment for severe SAD
Blanco et al. 2010 landmark RCT: combined CBT-SAD + phenelzine produced significantly better outcomes than either alone for severe generalised SAD. Blanco 2013 replicated with paroxetine + CBT.
Blanco et al. 2010 · 2013 Arch Gen Psychiatry · Davidson 2004 combined-treatment RCT.
🌐
Internet CBT-SAD equivalence
Kampmann et al. 2016 meta of 21 iCBT-SAD RCTs: g=0.84 vs waitlist, effectively equivalent to face-to-face CBT-SAD. Andersson et al. 2017: 5-year follow-up shows sustained gains equal to in-person delivery.
Kampmann et al. 2016 · Andersson et al. 2014, 2017 World Psychiatry · Titov et al. 2010.
🎯
Comorbidity resolution
Successful CBT-SAD often improves comorbid depression (through reversed avoidance and social re-engagement) and reduces alcohol use — even without direct treatment of those conditions. The primary condition drove the secondary.
Blanco et al. 2013 secondary analyses · Erwin et al. 2002 · Chambless meta-analyses.
👥
Relationship & social network gains
Beyond symptom reduction, CBT-SAD consistently expands social network size, relationship quality, and intimacy at 12-month follow-up — the actual life outcomes people came in for. Effects grow with time as skills consolidate.
Rapee & Heimberg 1997 · Alden & Taylor 2004 · Kashdan et al. 2013.
Landmark Social Anxiety Studies · A Reference Timeline
The studies that built CBT-SAD.
Every clinical recommendation on this page traces back to specific pieces of research. Below is a curated timeline of the most influential SAD-specific studies — the ones that changed how social anxiety is understood, diagnosed, and treated. Use it to check the evidence base of any claim, anywhere.
First systematic cognitive model of anxiety including social phobia. Established the cognitive-behavioural template that later Clark & Wells and Heimberg models refined for SAD specifically.
1995
Clark & WellsChapter in Heimberg et al. (Guilford)
Theoretical model
The Clark & Wells cognitive model of SAD — four maintaining factors: self-focused attention, safety behaviours, negative self-image, post-event rumination. Foundation of the gold-standard individual CBT-SAD protocol.
1997
Rapee & HeimbergBehav Res Ther
Cognitive-behavioural model
Alternative cognitive-behavioural model of SAD emphasising perceived audience appraisal. Basis for the Heimberg group CBT protocol (CBGT).
2007
HofmannClin Psychol Rev
Comprehensive review
Integration of cognitive models with emotion-regulation theory for SAD. Established rumination and post-event processing as key intervention targets.
Diagnostic Criteria & Epidemiology
Year
Authors · Journal
Design · N
Key Finding · Clinical Implication
1980
APADSM-III
Consensus revision
First formal recognition of "Social Phobia" as a distinct anxiety disorder. Established the diagnostic entity that would be renamed Social Anxiety Disorder in DSM-IV and refined in DSM-5.
1999
Wittchen et al.Psychol Med
Community · N=3,021
Epidemiology of SAD in young adults · onset typically 11-15 years, average 15-year delay to treatment. Established the "silent disorder" nature of untreated SAD.
2005
Kessler et al.Arch Gen Psychiatry
NCS-R · N=9,282
Lifetime prevalence of SAD ~12.1% (3rd most common mental disorder). ~70% develop another disorder in lifetime — most often depression, alcohol use, panic.
2013
APADSM-5
Consensus revision
DSM-5 renamed "Social Phobia" to "Social Anxiety Disorder" (300.23), added "performance only" specifier, removed age-of-onset requirement. Reflects modern understanding of the disorder.
SAD Treatment Trials & Meta-Analyses
Year
Authors · Journal
Design · N
Key Finding · Clinical Implication
1990
Heimberg et al.Behav Ther
RCT · CBGT
First controlled trial of Cognitive-Behavioural Group Therapy (CBGT) for SAD. Established the 12-week Heimberg protocol as effective group treatment. Foundation of decades of subsequent CBGT research.
1998
Mattick & ClarkeBehav Res Ther
Scale development
Development and validation of SIAS and SPS — companion instruments distinguishing interaction anxiety from performance anxiety. Now standard SAD assessment.
2003
Clark et al.J Consult Clin Psychol
RCT · N=60
Cognitive therapy vs exposure alone for SAD: cognitive therapy (Clark & Wells protocol) significantly superior. Established the individual Clark & Wells protocol as first-line individual CBT-SAD.
2008
Powers, Sigmarsson & EmmelkampInt J Cogn Ther
Meta · 32 RCTs
CBT for SAD produces effect size g=0.62-0.68 vs waitlist controls. Established meta-analytic evidence for CBT-SAD across delivery formats.
2010
Blanco et al.Arch Gen Psychiatry
RCT · N=128
Combined CBT + phenelzine significantly outperforms either alone for severe generalised SAD. Landmark trial establishing combined treatment for severe presentations.
2014
Mayo-Wilson et al.Lancet Psychiatry
Network meta · 101 trials · N=13,164
Individual CBT-SAD produced the largest effect size (SMD -1.19) of any SAD treatment. Definitive evidence hierarchy: individual CBT-SAD > group CBT-SAD > SSRIs > iCBT-SAD > other.
2016
Kampmann et al.Cognit Behav Ther
Meta · 21 iCBT-SAD trials
Internet-delivered CBT for SAD: g=0.84 vs waitlist, equivalent to face-to-face delivery. Foundational evidence for scaling online CBT-SAD.
2018
Andrews et al.PLoS ONE
Meta · long-term FU
CBT-SAD gains maintained at 3-5 year follow-up in majority of completers, unlike SSRI treatment (60-70% relapse within 6 months of discontinuation).
SAD Pharmacotherapy & Combined Treatment
Year
Authors · Journal
Design · N
Key Finding · Clinical Implication
1999
FDA · Stein et al.JAMA
RCT · paroxetine
Paroxetine first SSRI FDA-approved for SAD. RCT established SSRI efficacy for generalised SAD.
2003
FDA · Liebowitz et al.J Clin Psychopharmacol
RCT · venlafaxine XR
Venlafaxine XR FDA-approved for SAD. Established SNRI as effective for SAD, particularly SSRI non-responders.
2008
Stein & SteinLancet
Seminar review
Comprehensive review of SAD epidemiology, neurobiology, and treatment. Established the definitive modern clinical framework for SAD across mental health.
2013
Blanco et al.Arch Gen Psychiatry
RCT · CBT + paroxetine
Combined CBT-SAD + paroxetine outperforms either alone for severe SAD. Replicated the 2010 finding with more commonly-prescribed medication.
Adjacent Modalities · ACT, MCT, Attention Training
Year
Authors · Journal
Design · N
Key Finding · Clinical Implication
2007
Dalrymple & HerbertBehav Modif
RCT · ACT for SAD
First controlled trial of ACT for generalised SAD. Established ACT as viable alternative to traditional CBT for SAD.
2009
WellsMetacognitive Therapy (Guilford)
Book · treatment manual
Metacognitive Therapy manual for anxiety disorders including SAD. Established MCT approach targeting rumination and worry.
2012
Wells et al.Behav Res Ther
RCT · MCT for SAD
Metacognitive Therapy shows equivalent outcomes to CBT for SAD with faster onset of change on post-event processing.
2013
Kocovski et al.Behav Res Ther
RCT · ACT vs CBGT
Head-to-head trial: ACT and CBGT produced equivalent outcomes for SAD. Established ACT as evidence-based alternative for those who prefer acceptance-based approach.
Frequently Asked SAD Questions
Questions people with SAD ask us every day.
Direct answers to what our SAD clients actually ask — not clinical jargon.
Is CBT-SAD actually different from regular therapy? ▾
Yes — significantly. Clark & Wells CBT-SAD is a structured 14-16 session protocol specifically targeting the four maintaining factors of social anxiety: self-focused attention, safety behaviours, negative self-image, and post-event rumination. It uses specific techniques (video-feedback, behavioural experiments, attention refocus) that generic therapy or generic CBT don't include. Mayo-Wilson 2014 Lancet Psychiatry network meta-analysis: individual CBT-SAD produced the largest effect size (SMD -1.19) of any SAD treatment, larger than generic CBT, SSRIs, or other approaches.
How do I know if I have SAD or if I'm just shy? ▾
Shyness is a temperament trait; SAD is a clinical disorder with specific DSM-5 criteria (300.23). The distinction: SAD involves persistent fear of social/performance situations, active avoidance or endurance with intense distress, functional impairment (work, social, education), and the fear is out of proportion to the actual social threat. If your fear consistently prevents you doing things you want to do, or affects your career/relationships/mood, it's worth taking the Mini-SPIN screener above. A score ≥6 suggests likely SAD warranting evaluation.
Can I book without a phone call — I can't make phone calls easily. ▾
Absolutely — this is our most common request from SAD clients. You can book entirely by WhatsApp chat, no phone call ever required. Some clients even do their first session by chat/text (all our therapists accommodate this for SAD specifically) then move to video/audio when they feel ready. Just message us at +91-98993-99516 on WhatsApp; we'll book you in without a single phone call.
Will medication cure my social anxiety? ▾
SSRIs (paroxetine, sertraline, escitalopram, fluvoxamine) and venlafaxine XR are FDA-approved for SAD and genuinely help — response rates 50-70% at 12 weeks. But: (1) they reduce symptoms, they don't "cure" the underlying learned patterns; (2) 60-70% of people relapse within 6 months of stopping unless they also had CBT-SAD; (3) they take 4-8 weeks to work; (4) they have side effects. For severe SAD or SAD+depression, combined CBT-SAD + SSRI is optimal (Blanco 2010). For mild-to-moderate SAD, CBT-SAD alone typically produces durable, medication-free improvement.
How long does CBT-SAD take? ▾
Standard Clark & Wells individual CBT-SAD: 14-16 weekly sessions (~4 months). Heimberg group CBGT: 12 weekly 2.5-hour sessions (~3 months). Performance-only SAD often responds to 8-12 sessions. Severe or comorbid SAD may need 20+ sessions plus SSRI. First visible LSAS/SPIN reduction typically at week 4-6; substantial improvement at week 8-12; consolidation and relapse-prevention through week 12-16.
Is online CBT-SAD as good as in-person? ▾
Yes — Kampmann et al. 2016 meta-analysis of 21 iCBT-SAD RCTs found g=0.84 vs waitlist, effectively equivalent to face-to-face CBT-SAD. Andersson et al. 2017 showed 5-year sustained gains equal to in-person delivery. For many people with SAD, online is actually easier — you don't have to face a waiting room, reception, or in-person eye contact until you're ready to. Video-feedback exercises work particularly well online since you're already looking at a screen.
What about the exposure part — do I have to do things I'm terrified of? ▾
Modern CBT-SAD uses collaborative graded exposure with behavioural experiments — you build your own hierarchy of feared situations, you set the pace, nothing is ever forced. Early sessions build the cognitive framework and internal skills first (attention refocus, safety-behaviour identification) so that when exposure begins, you're equipped. Exposures are designed as experiments to test specific predictions ("if I don't rehearse, I'll freeze") rather than endurance tests. Most clients report the exposures felt manageable — and that avoiding them for years was worse than doing them.
I drink to cope with social situations — will I have to stop? ▾
Not immediately, but eventually yes — for the CBT-SAD to work. Alcohol prevents disconfirmation of feared predictions ("I got through it because I was buzzed, not because it was actually fine"), so it blocks the exposure-based learning. We usually work on the alcohol pattern using motivational interviewing in parallel with CBT-SAD, and time intensive exposures for sober periods. If alcohol use is severe (AUDIT-C flagged), we coordinate with an addiction specialist first. About 48% of SAD clients have alcohol use as a factor — you are not unusual.
What if my SAD is only around specific situations (public speaking)? ▾
Performance-only SAD (DSM-5 specifier "performance only") responds well to a shorter focused CBT-SAD protocol (8-12 sessions) plus situational propranolol — a beta-blocker taken 45-60 min before specific performances (presentations, exams, viva, recitals). Propranolol blocks the physical symptoms (hand tremor, voice tremor, palpitations) without affecting cognition or being addictive. Used by musicians, actors, teachers, lawyers, surgeons for decades. Requires prescription from our psychiatrist after cardiovascular screening.
How does HopeQure protect my privacy? ▾
HopeQure is HIPAA and GDPR aligned, ISO 27001 certified, and compliant with the Indian Digital Personal Data Protection Act (DPDPA) 2023 and Mental Healthcare Act 2017. All video sessions are end-to-end encrypted. Session notes are stored under clinical-record protections. Session content is never shared with your employer (even for EAP-covered clients), insurance company, or anyone else without your explicit written consent. Our DPO is at dpo@hopequre.com.
Free CBT-SAD Toolkit · Download & Use Between Sessions
Practical templates for real CBT-SAD work.
Six SAD-specific templates our CBT-SAD clinicians use with clients every week. Free to download, adapt to your life, and print. No account required.
PDF · 2 pages
Exposure Hierarchy Builder for SAD
Structured worksheet to build your personalised SAD exposure ladder. List 15-20 feared social situations, rate each on SUDS (0-100 fear rating), sort into low/medium/high tiers. Foundation for graded exposure work.
Modified Beck-model thought record specifically for social anxiety predictions: situation → prediction ("they'll think I'm stupid") → evidence for/against → actual outcome vs predicted. Central tool of Clark & Wells CBT-SAD.
Inventory of common SAD safety behaviours (rehearsing what to say, avoiding eye contact, checking phone, drinking beforehand, over-preparing). Identify yours, then plan drops. Core CBT-SAD case formulation tool.
Structured technique from Clark & Wells for interrupting the mental replay/rumination after social events. Notice trigger → apply 3-step interruption → refocus attention outward. Reduces the second-loop of SAD.
Guided reflection for after you review a video recording of yourself in a social interaction. Compare what you actually looked like vs your imagined self-image (usually a huge gap). Powerful for correcting negative self-image.
10-minute pre-session template. Since booking and attending sessions can itself feel hard with SAD, this guide walks you through what to think about beforehand, what to expect in each session type, and how to make the most of your time.
All six templates are drawn from Clark & Wells (1995) individual CBT-SAD protocol, Heimberg group CBGT manual, and Wells (2009) metacognitive therapy. Free for personal use; not a substitute for structured CBT-SAD with a trained clinician.
Editorially Reviewed & Evidence-Based
Medical Review Board
Every clinical claim on this SAD page has been reviewed by our medical board — CBT-SAD-trained clinicians with active practice, board certification, and specific training in Clark & Wells CBT-SAD, Heimberg group CBT, MCT, ACT for SAD, and SAD pharmacotherapy. Content is refreshed every 12 months or when significant new SAD guidelines are published.
Dr. Preeti Sharma
MBBS, MD Psychiatry · Registered · 7+ yrs
Reviewed SAD medication content (SSRIs, venlafaxine XR, situational propranolol), differential-diagnosis pathways (SAD vs AvPD vs autism spectrum vs ADHD), and the psychiatric-consultation sections. Practises adult psychiatry with focus on anxiety disorders including SAD on HopeQure.
Reviewed CBT-SAD approach descriptions (Clark & Wells individual, Heimberg group, ACT for SAD, MCT, ATT), SAD-specific screening-instrument scoring (LSAS, SPIN, SIAS-6, BFNE, Mini-SPIN), HIPAA/GDPR/DPDP compliance, and cross-border prescribing safeguards.
HopeQure Editorial Standards
HONcode-aligned · WHO best-practice
Content follows evidence-hierarchy: peer-reviewed research > guideline documents > expert consensus. No promotional claims. No pop-psychology shortcuts.
Last reviewed: September 2026 (SAD-specific rebuild)Next review: September 2027Editorial policy:Read our standards →
📚 Full References Cited on This Page
Clinical Practice Guidelines
American Psychological Association. Clinical Practice Guideline for the Treatment of Depression Across Three Age Cohorts. Washington DC: APA; 2019.
American Psychological Association. Guidelines for the Practice of Telepsychology. Washington DC: APA; 2013 (revised 2020).
National Institute for Health and Care Excellence. Depression in adults: treatment and management. NICE Guideline NG222. 2022.
National Institute for Health and Care Excellence. Generalised anxiety disorder and panic disorder in adults: management. NICE CG113. 2011 (updated 2020).
National Institute for Health and Care Excellence. Post-traumatic stress disorder. NICE Guideline NG116. 2018.
World Health Organization. mhGAP Intervention Guide for Mental, Neurological and Substance Use Disorders. Version 2.0. Geneva: WHO; 2016.
World Health Organization. World Mental Health Report: Transforming Mental Health for All. Geneva: WHO; 2022.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-5-TR). Washington DC: APA; 2022.
Assessment Instruments
Kroenke K., Spitzer R.L., Williams J.B.W. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606-613.
Spitzer R.L., Kroenke K., Williams J.B.W., Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092-1097.
Kessler R.C., Andrews G., Colpe L.J., et al. Short screening scales to monitor population prevalences and trends in non-specific psychological distress (K10). Psychol Med. 2002;32(6):959-976.
Lovibond P.F., Lovibond S.H. The structure of negative emotional states: DASS-21/DASS-42 comparison with the Beck Depression and Anxiety Inventories. Behav Res Ther. 1995;33(3):335-343.
Cohen S., Kamarck T., Mermelstein R. A global measure of perceived stress (PSS-10). J Health Soc Behav. 1983;24(4):385-396.
Morin C.M., Belleville G., Bélanger L., Ivers H. The Insomnia Severity Index: psychometric indicators to detect insomnia cases and evaluate treatment response. Sleep. 2011;34(5):601-608.
Tennant R., Hiller L., Fishwick R., et al. The Warwick-Edinburgh Mental Well-Being Scale (WEMWBS): development and UK validation. Health Qual Life Outcomes. 2007;5:63.
Barkham M., Bewick B., Mullin T., et al. The CORE-10: a short measure of psychological distress for routine outcome monitoring. Couns Psychother Res. 2013;13(1):3-13.
Diener E., Emmons R.A., Larsen R.J., Griffin S. The Satisfaction With Life Scale (SWLS). J Pers Assess. 1985;49(1):71-75.
Blevins C.A., Weathers F.W., Davis M.T., Witte T.K., Domino J.L. The Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5): development and initial psychometric evaluation. J Trauma Stress. 2015;28(6):489-498.
Prins A., Bovin M.J., Smolenski D.J., et al. The Primary Care PTSD Screen for DSM-5 (PC-PTSD-5): development and evaluation within a veteran primary care sample. J Gen Intern Med. 2016;31(10):1206-1211.
Bush K., Kivlahan D.R., McDonell M.B., Fihn S.D., Bradley K.A. The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Arch Intern Med. 1998;158(16):1789-1795.
Saunders J.B., Aasland O.G., Babor T.F., de la Fuente J.R., Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT). Addiction. 1993;88(6):791-804.
Kessler R.C., Adler L., Ames M., et al. The World Health Organization Adult ADHD Self-Report Scale (ASRS): a short screening scale for use in the general population. Psychol Med. 2005;35(2):245-256.
Nolen-Hoeksema S., Morrow J. A prospective study of depression and posttraumatic stress symptoms after a natural disaster: the Ruminative Responses Scale. J Pers Soc Psychol. 1991;61(1):115-121.
WHOQOL Group. Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychol Med. 1998;28(3):551-558.
Epidemiology & Prevalence
World Health Organization. World Mental Health Report 2022: an estimated 970 million people were living with a mental disorder in 2019; depression 4.4% and anxiety 3.6% of global population.
GBD 2019 Mental Disorders Collaborators. Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990-2019. Lancet Psychiatry. 2022;9(2):137-150.
Kessler R.C., Chiu W.T., Demler O., Walters E.E. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):617-627.
Steel Z., Marnane C., Iranpour C., et al. The global prevalence of common mental disorders: a systematic review and meta-analysis 1980-2013. Int J Epidemiol. 2014;43(2):476-493.
Santomauro D.F., Mantilla Herrera A.M., Shadid J., et al. Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic. Lancet. 2021;398(10312):1700-1712.
Wang P.S., Aguilar-Gaxiola S., Alonso J., et al. Use of mental health services for anxiety, mood, and substance disorders in 17 countries in the WHO world mental health surveys (treatment gap). Lancet. 2007;370(9590):841-850.
Neuroscience & Mechanisms of Change
Kandel E.R. A new intellectual framework for psychiatry. Am J Psychiatry. 1998;155(4):457-469.
Etkin A., Pittenger C., Polan H.J., Kandel E.R. Toward a neurobiology of psychotherapy: basic science and clinical applications. J Neuropsychiatry Clin Neurosci. 2005;17(2):145-158.
DeRubeis R.J., Siegle G.J., Hollon S.D. Cognitive therapy versus medication for depression: treatment outcomes and neural mechanisms. Nat Rev Neurosci. 2008;9(10):788-796.
Barsaglini A., Sartori G., Benetti S., Pettersson-Yeo W., Mechelli A. The effects of psychotherapy on brain function: a systematic and critical review. Prog Neurobiol. 2014;114:1-14.
Karlsson H., Hirvonen J., Kajander J., et al. Research letter: Psychotherapy increases brain serotonin 5-HT1A receptors in patients with major depressive disorder. Psychol Med. 2010;40(3):523-528.
Social Anxiety Disorder — Landmark Studies
Clark D.M., Wells A. A cognitive model of social phobia. In: Heimberg R.G., Liebowitz M.R., Hope D.A., Schneier F.R. (eds). Social Phobia: Diagnosis, Assessment, and Treatment. New York: Guilford Press; 1995:69-93.
Rapee R.M., Heimberg R.G. A cognitive-behavioral model of anxiety in social phobia. Behav Res Ther. 1997;35(8):741-756.
Liebowitz M.R. Social phobia. Mod Probl Pharmacopsychiatry. 1987;22:141-173. (Original Liebowitz Social Anxiety Scale)
Connor K.M., Davidson J.R.T., Churchill L.E., Sherwood A., Foa E., Weisler R.H. Psychometric properties of the Social Phobia Inventory (SPIN): new self-rating scale. Br J Psychiatry. 2000;176:379-386.
Connor K.M., Kobak K.A., Churchill L.E., Katzelnick D., Davidson J.R. Mini-SPIN: A brief screening assessment for generalized social anxiety disorder. Depress Anxiety. 2001;14(2):137-140.
Mattick R.P., Clarke J.C. Development and validation of measures of social phobia scrutiny fear and social interaction anxiety (SIAS/SPS). Behav Res Ther. 1998;36(4):455-470.
Peters L., Sunderland M., Andrews G., Rapee R.M., Mattick R.P. Development of a short form Social Interaction Anxiety (SIAS-6) and Social Phobia (SPS-6) Scale. Psychol Assess. 2012;24(1):66-76.
Leary M.R. A brief version of the Fear of Negative Evaluation Scale (BFNE). Pers Soc Psychol Bull. 1983;9(3):371-375.
Kessler R.C., Berglund P., Demler O., Jin R., Merikangas K.R., Walters E.E. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication (SAD ~12.1% lifetime, onset 11-15). Arch Gen Psychiatry. 2005;62(6):593-602.
Wittchen H.U., Stein M.B., Kessler R.C. Social fears and social phobia in a community sample of adolescents and young adults: prevalence, risk factors and co-morbidity. Psychol Med. 1999;29(2):309-323.
Ruscio A.M., Brown T.A., Chiu W.T., Sareen J., Stein M.B., Kessler R.C. Social fears and social phobia in the USA: results from the National Comorbidity Survey Replication. Psychol Med. 2008;38(1):15-28.
Wang P.S., Berglund P., Olfson M., et al. Failure and delay in initial treatment contact after first onset of mental disorders (SAD 15-year avg delay). Arch Gen Psychiatry. 2005;62(6):603-613.
CBT-SAD Treatment Trials & Meta-Analyses
Mayo-Wilson E., Dias S., Mavranezouli I., et al. Psychological and pharmacological interventions for social anxiety disorder in adults: a systematic review and network meta-analysis. Lancet Psychiatry. 2014;1(5):368-376. (Definitive network meta-analysis · Individual CBT-SAD SMD -1.19)
Heimberg R.G., Dodge C.S., Hope D.A., Kennedy C.R., Zollo L.J., Becker R.E. Cognitive behavioral group treatment for social phobia: comparison with a credible placebo control. Cognit Ther Res. 1990;14(1):1-23.
Clark D.M., Ehlers A., McManus F., et al. Cognitive therapy versus fluoxetine in generalized social phobia: a randomized placebo-controlled trial. J Consult Clin Psychol. 2003;71(6):1058-1067.
Powers M.B., Sigmarsson S.R., Emmelkamp P.M.G. A meta-analytic review of psychological treatments for social anxiety disorder. Int J Cogn Ther. 2008;1(2):94-113.
Hofmann S.G., Smits J.A. Cognitive-behavioral therapy for adult anxiety disorders: a meta-analysis of randomized placebo-controlled trials. J Clin Psychiatry. 2008;69(4):621-632.
Kampmann I.L., Emmelkamp P.M., Morina N. Meta-analysis of technology-assisted interventions for social anxiety disorder. J Anxiety Disord. 2016;42:71-84. (iCBT-SAD g=0.84)
Andrews G., Basu A., Cuijpers P., et al. Computer therapy for the anxiety and depression disorders is effective, acceptable and practical health care: an updated meta-analysis. J Anxiety Disord. 2018;55:70-78.
Feske U., Chambless D.L. Cognitive behavioral versus exposure only treatment for social phobia: a meta-analysis. Behav Ther. 1995;26(4):695-720.
Dalrymple K.L., Herbert J.D. Acceptance and commitment therapy for generalized social anxiety disorder: a pilot study. Behav Modif. 2007;31(5):543-568.
Kocovski N.L., Fleming J.E., Hawley L.L., Huta V., Antony M.M. Mindfulness and acceptance-based group therapy versus traditional cognitive behavioral group therapy for social anxiety disorder: a randomized controlled trial. Behav Res Ther. 2013;51(12):889-898.
Wells A. Metacognitive Therapy for Anxiety and Depression. New York: Guilford Press; 2009.
Wells A., White J., Carter K. Attention training: effects on anxiety and beliefs in panic and social phobia. Clin Psychol Psychother. 1997;4(4):226-232.
Papageorgiou C., Wells A. Effects of attention training on hypochondriasis: a brief case series. Psychol Med. 2000;30(1):193-200.
SAD Pharmacotherapy & Combined Treatment
Stein M.B., Liebowitz M.R., Lydiard R.B., Pitts C.D., Bushnell W., Gergel I. Paroxetine treatment of generalized social phobia (social anxiety disorder): a randomized controlled trial. JAMA. 1998;280(8):708-713.
Liebowitz M.R., Gelenberg A.J., Munjack D. Venlafaxine extended release vs placebo and paroxetine in social anxiety disorder. Arch Gen Psychiatry. 2005;62(2):190-198.
Blanco C., Heimberg R.G., Schneier F.R., et al. A placebo-controlled trial of phenelzine, cognitive behavioral group therapy, and their combination for social anxiety disorder. Arch Gen Psychiatry. 2010;67(3):286-295. (Landmark combined-treatment RCT)
Blanco C., Bragdon L.B., Schneier F.R., Liebowitz M.R. The evidence-based pharmacotherapy of social anxiety disorder. Int J Neuropsychopharmacol. 2013;16(1):235-249.
Davidson J.R.T., Foa E.B., Huppert J.D., et al. Fluoxetine, comprehensive cognitive behavioral therapy, and placebo in generalized social phobia. Arch Gen Psychiatry. 2004;61(10):1005-1013.
National Institute for Health and Care Excellence. Social anxiety disorder: recognition, assessment and treatment. NICE Clinical Guideline CG159. 2013.
SAD Comorbidity & Self-Medication
Buckner J.D., Schmidt N.B., Lang A.R., Small J.W., Schlauch R.C., Lewinsohn P.M. Specificity of social anxiety disorder as a risk factor for alcohol and cannabis dependence. J Psychiatr Res. 2008;42(3):230-239.
Katzelnick D.J., Kobak K.A., DeLeire T., et al. Impact of generalized social anxiety disorder in managed care. Am J Psychiatry. 2001;158(12):1999-2007.
Fresco D.M., Coles M.E., Heimberg R.G., et al. The Liebowitz Social Anxiety Scale: a comparison of the psychometric properties of self-report and clinician-administered formats. Psychol Med. 2001;31(6):1025-1035.
Rachman S., Grüter-Andrew J., Shafran R. Post-event processing in social anxiety (PEPQ). Behav Res Ther. 2000;38(6):611-617.
Treatment Efficacy — Foundational & Common Factors
Rogers C.R. The necessary and sufficient conditions of therapeutic personality change. J Consult Psychol. 1957;21(2):95-103.
Beck A.T. Cognitive Therapy and the Emotional Disorders. New York: International Universities Press; 1976.
Linehan M.M. Cognitive-Behavioral Treatment of Borderline Personality Disorder. New York: Guilford Press; 1993.
Hayes S.C., Strosahl K.D., Wilson K.G. Acceptance and Commitment Therapy: An Experiential Approach to Behavior Change. New York: Guilford Press; 1999.
Wampold B.E. The Great Psychotherapy Debate: Models, Methods, and Findings. Mahwah, NJ: Lawrence Erlbaum; 2001.
Lambert M.J. (ed). Bergin and Garfield's Handbook of Psychotherapy and Behavior Change. 6th ed. Wiley; 2013.
Norcross J.C., Wampold B.E. Evidence-based therapy relationships: research conclusions and clinical practices. Psychotherapy. 2011;48(1):98-102.
Treatment Efficacy — Meta-Analyses & RCTs
Cuijpers P., Berking M., Andersson G., Quigley L., Kleiboer A., Dobson K.S. A meta-analysis of cognitive-behavioural therapy for adult depression, alone and in comparison with other treatments. Can J Psychiatry. 2013;58(7):376-385.
Cuijpers P., van Straten A., Andersson G., van Oppen P. Psychotherapy for depression in adults: a meta-analysis of comparative outcome studies. J Consult Clin Psychol. 2008;76(6):909-922.
Cuijpers P., Sijbrandij M., Koole S.L., Andersson G., Beekman A.T., Reynolds C.F. The efficacy of psychotherapy and pharmacotherapy in treating depressive and anxiety disorders: a meta-analysis of direct comparisons. World Psychiatry. 2013;12(2):137-148.
Hofmann S.G., Asnaani A., Vonk I.J.J., Sawyer A.T., Fang A. The efficacy of cognitive behavioral therapy: a review of meta-analyses. Cognit Ther Res. 2012;36(5):427-440.
Cipriani A., Furukawa T.A., Salanti G., et al. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet. 2018;391(10128):1357-1366.
Kuyken W., Warren F.C., Taylor R.S., et al. Efficacy of mindfulness-based cognitive therapy in prevention of depressive relapse: an individual patient data meta-analysis from randomized trials. JAMA Psychiatry. 2016;73(6):565-574.
Segal Z.V., Williams J.M.G., Teasdale J.D. Mindfulness-Based Cognitive Therapy for Depression. 2nd ed. New York: Guilford Press; 2013.
Weissman M.M., Markowitz J.C., Klerman G.L. The Guide to Interpersonal Psychotherapy. Updated and expanded. Oxford University Press; 2017.
Shapiro F. Eye Movement Desensitization and Reprocessing (EMDR): Basic Principles, Protocols, and Procedures. 3rd ed. New York: Guilford Press; 2018.
Bisson J.I., Roberts N.P., Andrew M., Cooper R., Lewis C. Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults. Cochrane Database Syst Rev. 2013;12:CD003388.
Shedler J. The efficacy of psychodynamic psychotherapy. Am Psychol. 2010;65(2):98-109.
Online / Digital Therapy Efficacy
Andersson G., Cuijpers P., Carlbring P., Riper H., Hedman E. Guided internet-based vs face-to-face cognitive behavior therapy for psychiatric and somatic disorders: a systematic review and meta-analysis. World Psychiatry. 2014;13(3):288-295.
Karyotaki E., Efthimiou O., Miguel C., et al. Internet-based cognitive behavioral therapy for depression: a systematic review and individual patient data network meta-analysis. JAMA Psychiatry. 2021;78(4):361-371.
Berger T. The therapeutic alliance in internet interventions: a narrative review and suggestions for future research. Psychother Res. 2017;27(5):511-524.
Berryhill M.B., Culmer N., Williams N., et al. Videoconferencing psychotherapy and depression: a systematic review. Telemed J E Health. 2019;25(6):435-446.
Barak A., Hen L., Boniel-Nissim M., Shapira N. A comprehensive review and a meta-analysis of the effectiveness of internet-based psychotherapeutic interventions. J Technol Hum Serv. 2008;26(2-4):109-160.
Real-World Programmes & Health-Systems Outcomes
Unützer J., Katon W., Callahan C.M., et al. Collaborative care management of late-life depression in the primary care setting: the IMPACT randomized controlled trial. JAMA. 2002;288(22):2836-2845.
Layard R., Clark D., Bell S., et al. The depression report: a new deal for depression and anxiety disorders (foundation of UK IAPT). London: LSE Centre for Economic Performance; 2006.
Clark D.M. Realizing the mass public benefit of evidence-based psychological therapies: the IAPT program. Annu Rev Clin Psychol. 2018;14:159-183.
Baglioni C., Battagliese G., Feige B., et al. Insomnia as a predictor of depression: a meta-analytic evaluation of longitudinal epidemiological studies. J Affect Disord. 2011;135(1-3):10-19.
Chisholm D., Sweeny K., Sheehan P., et al. Scaling-up treatment of depression and anxiety: a global return on investment analysis. Lancet Psychiatry. 2016;3(5):415-424.
Katon W.J., Lin E.H., Von Korff M., et al. Collaborative care for patients with depression and chronic illnesses. N Engl J Med. 2010;363(27):2611-2620.
Regulatory & Data-Protection Frameworks
Government of India, Ministry of Health and Family Welfare. Telemedicine Practice Guidelines 2020.
Government of India. Mental Healthcare Act 2017 · Section 23 (right to access mental healthcare).
Government of India. Digital Personal Data Protection Act 2023.
US Department of Health & Human Services. HIPAA Privacy, Security and Breach Notification Rules.
European Union. General Data Protection Regulation (GDPR). Regulation (EU) 2016/679.
This reference list focuses on social anxiety disorder and its evidence-based psychotherapies — among the most heavily researched areas in clinical psychology, with thousands of published papers. Above are the specific studies whose findings or numbers are quoted on this SAD-focused page. For a definitive current-state-of-evidence overview of SAD specifically, we recommend Mayo-Wilson et al. 2014 Lancet Psychiatry network meta-analysis (ref #48), Stein & Stein 2008 Lancet Seminar (ref #64), and NICE CG159 Social Anxiety Disorder (ref #66). For internet-delivered CBT-SAD specifically, Kampmann 2016 (ref #53) and Andrews 2018 (ref #54).
Related HopeQure Services
Working on more than one thing?
Because ~70% of people with SAD have another concern layered on, here are eight HopeQure services commonly used alongside CBT-SAD. Your care coordinator can weave any of these into an integrated care plan.
HopeQure is HIPAA and GDPR aligned, ISO 27001 certified, and follows the highest global standards for mental-health data confidentiality. Therapy notes and psychiatric records are treated with the highest sensitivity. Nothing goes to your employer, insurer, family or anyone else without your explicit written consent.
🌍 Any country🕐 Any time zone📱 Any device🗣 13+ languages🎥 Video · Audio · Chat💳 Secure payment🔐 GDPR & HIPAA aligned🏆 4.5/5 · 48,650+ clients
Delivering evidence-based online therapy and psychiatric care worldwide via secure video consultation. Licensed clinicians, APA/NICE-aligned care, adapted to your language and context.
One First Step
SAD stole 15 years from most people. Don't give it another one.
The hardest part of getting help for social anxiety is the getting help part — the booking, the phone call, the walking in. We've made every step of that as low-friction as we possibly can. Chat-only booking, chat-only first session if you need, no phone call ever required. 28 CBT-SAD specialists online right now. ₹999 first session with WELCOME10.
If you're in crisis, iCall (9152987821), Vandrevala Foundation (1860-2662-345), Tele-MANAS (14416) are available. HopeQure care coordinators are available on WhatsApp for non-emergency support daily 9am-9pm IST.
Request a callback
Our care coordinator will call within 10 minutes (8 AM – 11 PM IST). Or if calling feels hard because of your SAD, tell us in the "Best time" field to reply by chat/WhatsApp only. Confidential, no obligation — happy to discuss whether CBT-SAD fits, which approach suits you, or your specific situation.
Understanding Social Anxiety &
Your Treatment Options
Social anxiety can affect how you feel, think and behave in everyday social situations. Learn more about its different presentations, CBT techniques, symptoms and evidence-based treatment approaches in our complete guide.
Types of
Social Anxiety
Understand the different ways social anxiety can present and how these patterns can affect everyday life.
CBT &
Social Anxiety
Learn what research says about CBT and why it is commonly used to help manage social anxiety.
CBT
Techniques
Explore practical CBT skills and techniques used to work through social anxiety.
Common
Presentations
Recognise common symptoms and patterns of social anxiety across different situations.
Treatment
Approaches
Explore evidence-based approaches used in the treatment of social anxiety.